找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomarkers in Liver Disease; Vinood B. Patel,Victor R. Preedy Reference work 2017 Springer Science+Business Media Dordrecht 2017 Applicati

[復制鏈接]
樓主: False-Negative
21#
發(fā)表于 2025-3-25 04:33:19 | 只看該作者
Interaction of Sialyltransferases, Sialidases, and Sialic Acids in Liver Diseases and Applications teen evaluated in liver diseases, and significant alterations have been found. Detailed understanding of the role of sialic acid, sialidases, and sialyltransferases and their interactions in liver diseases may significantly contribute to open new exciting frontiers of basic and therapeutic exploratio
22#
發(fā)表于 2025-3-25 10:08:09 | 只看該作者
AST-to-Platelet Ratio Index (APRI) as Marker in Liver Diseaseant fibrosis. It showed promising results for predicting the presence of fibrosis in pediatric patients with NAFLD. Transient elastography, a noninvasive and objective but expensive method, showed higher performance in diagnosing significant fibrosis than APRI.
23#
發(fā)表于 2025-3-25 13:08:00 | 只看該作者
Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Diseasecant fibrosis exceeding standard diagnostic scores such as APRI and FIB-4. Lower levels are found in nonalcoholic fatty liver disease (NAFLD), but sCD163 adds diagnostic information on the important identification of patients with advanced disease..The emerging picture from the increasing number of
24#
發(fā)表于 2025-3-25 16:06:59 | 只看該作者
CD133 and EpCAM as Biomarkers in Liver Diseasesdifferentiation, migration, and cell survival. Wnt/β-catenin signaling pathway is the major pathway involved in EpCAM-positive hepatic cancers. CD133 and EpCAM have several significant clinical implications in diagnosis, prognosis, and therapy of human liver cancers. Recently defined histological ty
25#
發(fā)表于 2025-3-25 22:07:21 | 只看該作者
Graft-Derived Cell-Free DNA as a Biomarker in Liver Transplantationr more effective treatment intervention. It is especially helpful to guide changes in immunosuppression and to monitor immunosuppression minimization. This new approach may contribute to achieve more effective, less toxic personalized immunosuppression.
26#
發(fā)表于 2025-3-26 03:37:14 | 只看該作者
https://doi.org/10.1007/978-94-007-7675-3Application to prognosis; Biomarkers in disease; Cancer Research; Discovery of biomarkers; High throughp
27#
發(fā)表于 2025-3-26 06:52:39 | 只看該作者
28#
發(fā)表于 2025-3-26 11:33:23 | 只看該作者
29#
發(fā)表于 2025-3-26 13:14:09 | 只看該作者
Biomarkers in Disease: Methods, Discoveries and Applicationshttp://image.papertrans.cn/b/image/187816.jpg
30#
發(fā)表于 2025-3-26 18:11:27 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 04:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
图们市| 新龙县| 阿拉善左旗| 绥宁县| 鄯善县| 侯马市| 吉隆县| 叙永县| 丰城市| 临泽县| 黎川县| 裕民县| 祁东县| 墨竹工卡县| 青海省| 连州市| 满洲里市| 卓尼县| 左权县| 石城县| 新泰市| 若尔盖县| 郯城县| 兴业县| 杭锦后旗| 小金县| 遵化市| 海阳市| 临高县| 长武县| 太谷县| 屯留县| 讷河市| 阜南县| 沁阳市| 耒阳市| 隆昌县| 正安县| 盐池县| 宜川县| 承德市|